vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and Information Services Group Inc. (III). Click either name above to swap in a different company.
BillionToOne, Inc. is the larger business by last-quarter revenue ($83.5M vs $61.2M, roughly 1.4× Information Services Group Inc.). BillionToOne, Inc. runs the higher net margin — 6.8% vs 4.3%, a 2.6% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs 5.9%). BillionToOne, Inc. produced more free cash flow last quarter ($6.5M vs $4.3M).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
EBSCO Information Services, headquartered in Ipswich, Massachusetts, is a division of EBSCO Industries Inc., a private company headquartered in Birmingham, Alabama. EBSCO provides products and services to libraries of many types around the world. Its products include EBSCONET, a complete e-resource management system, and EBSCOhost, which supplies a fee-based online research service with 375 full-text databases, a collection of 600,000-plus ebooks, subject indexes, point-of-care medical refere...
BLLN vs III — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $61.2M |
| Net Profit | $5.7M | $2.6M |
| Gross Margin | 69.9% | 44.8% |
| Operating Margin | 11.5% | 8.4% |
| Net Margin | 6.8% | 4.3% |
| Revenue YoY | 117.4% | 5.9% |
| Net Profit YoY | 138.3% | -14.1% |
| EPS (diluted) | $0.10 | $0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $61.2M | ||
| Q3 25 | $83.5M | $62.4M | ||
| Q2 25 | — | $61.6M | ||
| Q1 25 | — | $59.6M | ||
| Q4 24 | — | $57.8M | ||
| Q3 24 | $38.4M | $61.3M | ||
| Q2 24 | — | $64.3M | ||
| Q1 24 | — | $64.3M |
| Q4 25 | — | $2.6M | ||
| Q3 25 | $5.7M | $3.1M | ||
| Q2 25 | — | $2.2M | ||
| Q1 25 | — | $1.5M | ||
| Q4 24 | — | $3.0M | ||
| Q3 24 | $-14.9M | $1.1M | ||
| Q2 24 | — | $2.0M | ||
| Q1 24 | — | $-3.4M |
| Q4 25 | — | 44.8% | ||
| Q3 25 | 69.9% | 42.2% | ||
| Q2 25 | — | 42.2% | ||
| Q1 25 | — | 43.1% | ||
| Q4 24 | — | 41.5% | ||
| Q3 24 | 52.6% | 40.4% | ||
| Q2 24 | — | 39.5% | ||
| Q1 24 | — | 36.1% |
| Q4 25 | — | 8.4% | ||
| Q3 25 | 11.5% | 7.4% | ||
| Q2 25 | — | 7.6% | ||
| Q1 25 | — | 5.7% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | -32.9% | 7.0% | ||
| Q2 24 | — | 5.7% | ||
| Q1 24 | — | -3.7% |
| Q4 25 | — | 4.3% | ||
| Q3 25 | 6.8% | 4.9% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 2.5% | ||
| Q4 24 | — | 5.3% | ||
| Q3 24 | -38.8% | 1.9% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | — | -5.3% |
| Q4 25 | — | $0.06 | ||
| Q3 25 | $0.10 | $0.06 | ||
| Q2 25 | — | $0.04 | ||
| Q1 25 | — | $0.03 | ||
| Q4 24 | — | $0.07 | ||
| Q3 24 | $-1.47 | $0.02 | ||
| Q2 24 | — | $0.04 | ||
| Q1 24 | — | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | $28.7M |
| Total DebtLower is stronger | $55.0M | — |
| Stockholders' EquityBook value | $-239.5M | $94.7M |
| Total Assets | $327.5M | $211.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $28.7M | ||
| Q3 25 | $195.2M | $28.7M | ||
| Q2 25 | — | $25.2M | ||
| Q1 25 | — | $20.1M | ||
| Q4 24 | — | $23.1M | ||
| Q3 24 | — | $9.7M | ||
| Q2 24 | — | $11.8M | ||
| Q1 24 | — | $14.0M |
| Q4 25 | — | — | ||
| Q3 25 | $55.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $94.7M | ||
| Q3 25 | $-239.5M | $94.7M | ||
| Q2 25 | — | $94.1M | ||
| Q1 25 | — | $95.0M | ||
| Q4 24 | — | $96.3M | ||
| Q3 24 | $-242.9M | $96.6M | ||
| Q2 24 | — | $95.5M | ||
| Q1 24 | — | $95.6M |
| Q4 25 | — | $211.0M | ||
| Q3 25 | $327.5M | $213.3M | ||
| Q2 25 | — | $200.7M | ||
| Q1 25 | — | $202.4M | ||
| Q4 24 | — | $204.5M | ||
| Q3 24 | — | $227.1M | ||
| Q2 24 | — | $235.3M | ||
| Q1 24 | — | $234.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | $5.1M |
| Free Cash FlowOCF − Capex | $6.5M | $4.3M |
| FCF MarginFCF / Revenue | 7.7% | 7.0% |
| Capex IntensityCapex / Revenue | 8.8% | 1.2% |
| Cash ConversionOCF / Net Profit | 2.42× | 1.94× |
| TTM Free Cash FlowTrailing 4 quarters | — | $25.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $5.1M | ||
| Q3 25 | $13.8M | $11.1M | ||
| Q2 25 | — | $11.9M | ||
| Q1 25 | — | $978.0K | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $8.8M | ||
| Q2 24 | — | $2.2M | ||
| Q1 24 | — | $2.3M |
| Q4 25 | — | $4.3M | ||
| Q3 25 | $6.5M | $9.5M | ||
| Q2 25 | — | $11.1M | ||
| Q1 25 | — | $141.0K | ||
| Q4 24 | — | $6.0M | ||
| Q3 24 | — | $8.4M | ||
| Q2 24 | — | $1.3M | ||
| Q1 24 | — | $1.3M |
| Q4 25 | — | 7.0% | ||
| Q3 25 | 7.7% | 15.2% | ||
| Q2 25 | — | 18.0% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 10.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.0% | ||
| Q1 24 | — | 2.0% |
| Q4 25 | — | 1.2% | ||
| Q3 25 | 8.8% | 2.5% | ||
| Q2 25 | — | 1.4% | ||
| Q1 25 | — | 1.4% | ||
| Q4 24 | — | 0.9% | ||
| Q3 24 | — | 0.6% | ||
| Q2 24 | — | 1.4% | ||
| Q1 24 | — | 1.6% |
| Q4 25 | — | 1.94× | ||
| Q3 25 | 2.42× | 3.62× | ||
| Q2 25 | — | 5.46× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 2.15× | ||
| Q3 24 | — | 7.66× | ||
| Q2 24 | — | 1.07× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
III
Segment breakdown not available.
